Suchergebnisse - "Colombo, Massimo G"

PubPharm (13)

1

Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma

enthalten in: World journal of gastrointestinal oncology | 2021

von Alqahtani, S. | Colombo, M.

2

Treating paediatric hepatitis C in the era of direct-acting antiviral agents

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2021

von Alqahtani, S. | Colombo, M.

3

Treating paediatric hepatitis C in the era of direct‐acting antiviral agents

enthalten in: Liver International | 2021

von Alqahtani, S. | Colombo, M.

4

Dynamic capabilities and high-tech entrepreneurial ventures' performance in the aftermath of an environmental jolt

enthalten in: Long range planning | 2020

von Colombo, M. | Piva, E. | Quas, A. | +1

5

The HepTestContest : a global innovation contest to identify approaches to hepatitis B and C testing

enthalten in: BMC infectious diseases | 2017

von Tucker, J. | Meyers, K. | Best, J. | +17

6

The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing

enthalten in: BMC infectious diseases | 2017

von Tucker, J. | Meyers, K. | Best, J. | +17

7

The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing

enthalten in: BMC infectious diseases | 2017

von Tucker, J. | Meyers, K. | Best, J. | +17

8

ENTREPRENEURSHIP. Cash from the crowd

enthalten in: Science (New York, N.Y.) | 2015

von Colombo, M. | Franzoni, C. | Rossi-Lamastra, C.

9

ENTREPRENEURSHIP. Cash from the crowd

enthalten in: Science | 2015

von Rossi-Lamastra, C. | Franzoni, C. | Colombo, M.

10

ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection

enthalten in: Gastroenterology | 2014

von Andreone, P. | Colombo, M. | Enejosa, J. | +11